NDC 0409-4520-02 - Heparin Sodium and Dextrose
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-4520
- Requested NDC
- 0409-4520-02
- Package NDCs from labels
- 0409-4520-02, 0409-4520-30
- Manufacturer
- Hospira, Inc.
- Effective date
- 2026-05-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Heparin Sodium and Dextrose - Hospira, Inc. | Hospira, Inc. | 2026-05-25 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-4520-02 | Heparin Sodium and Dextrose | 250 mL in 1 BAG | INJECTION, SOLUTION | 250 | 35 | |
| 0409-4520-30 | Heparin Sodium and Dextrose | 30 in 1 CASE | INJECTION, SOLUTION | 30 | 35 | |
| 0409-4520-30 | Heparin Sodium and Dextrose | 1 in 1 POUCH | INJECTION, SOLUTION | 1 | 35 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-4520-02 | ML - Milliliter | 0409-4520 | f5c76cd4-f5f9-4c80-a432-0d369f652ddb | 1 | 2023-01-09 |
| 0409-4520-30 | ML - Milliliter | 0409-4520 | 46269ff8-ea8d-46b3-8eff-8f08f30b655d | 1 | 2023-01-09 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HEPARIN SODIUM | ACTIVE INGREDIENT | ZZ45AB24CA | HEPARIN SODIUM AND DEXTROSE (HEPARIN SODIUM) INJECTION, SOLUTION [HOSPIRA, INC.] | 16 | |
| HEPARIN | ACTIVE MOIETY | T2410KM04A | HEPARIN SODIUM AND DEXTROSE (HEPARIN SODIUM) INJECTION, SOLUTION [HOSPIRA, INC.] | 16 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | HEPARIN SODIUM AND DEXTROSE (HEPARIN SODIUM) INJECTION, SOLUTION [HOSPIRA, INC.] | 16 | |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | LX22YL083G | HEPARIN SODIUM AND DEXTROSE (HEPARIN SODIUM) INJECTION, SOLUTION [HOSPIRA, INC.] | 16 | |
| SODIUM METABISULFITE | INACTIVE INGREDIENT | 4VON5FNS3C | HEPARIN SODIUM AND DEXTROSE (HEPARIN SODIUM) INJECTION, SOLUTION [HOSPIRA, INC.] | 16 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | HEPARIN SODIUM AND DEXTROSE (HEPARIN SODIUM) INJECTION, SOLUTION [HOSPIRA, INC.] | 16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Heparin Sodium | HEPARIN SODIUM | Gland Pharma Limited | 301b19bc-21c2-4a35-9d29-569b08d855c4 | 2026-11-03 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Henry Schein, Inc. | 3a998729-c912-4e21-8e49-d1e72ba6fe9e | 2026-11-02 | Warnings, Adverse reactions | ZZ45AB24CA |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | PAI Holdings, LLC dba PAI Pharma | 63201a61-6ac5-41ae-8b2d-ff0d3a8ddfd5 | 2026-10-30 | Adverse reactions | XF417D3PSL |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-10-30 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-10-30 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-10-30 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-10-30 | Warnings, Adverse reactions | LX22YL083G |
| Heparin Sodium | HEPARIN SODIUM | REMEDYREPACK INC. | a5fab0b1-c472-489c-ba87-2f8e53356173 | 2026-10-29 | Warnings, Adverse reactions | ZZ45AB24CA |
| QUALITY CHOICE Nausea Relief | SODIUM CITRATE DIHYDRATE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | d89e41c1-399a-4157-8d54-bfefe3b1c1cd | 2026-10-28 | Warnings | B22547B95K |
| Heparin Sodium in Sodium Chloride | HEPARIN SODIUM IN SODIUM CHLORIDE | B. Braun Medical Inc. | a3041c04-0ea8-4d36-81ce-c5091c906316 | 2026-10-26 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium in Sodium Chloride | HEPARIN SODIUM IN SODIUM CHLORIDE | B. Braun Medical Inc. | 8b030692-fc66-4c53-85aa-6f865e635618 | 2026-10-26 | Warnings, Adverse reactions | 1658717 ZZ45AB24CA |
| Heparin Sodium in Dextrose | HEPARIN SODIUM AND DEXTROSE | B. Braun Medical Inc. | 92a6f533-1a3d-4734-b413-d245592454e3 | 2026-10-26 | Warnings, Adverse reactions | 1658717 ZZ45AB24CA LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 5dceb1b4-e97a-a4fd-e063-6394a90a0392 | 2026-10-14 | Warnings, Adverse reactions | LX22YL083G |
| Emetrol Chewables | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | 9880a18a-cf84-47cd-99b5-d692065a25bf | 2026-09-24 | Warnings | B22547B95K |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | e2638b45-1141-4391-971d-c0dea825e41c | 2026-09-11 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 8cf6943f-16e8-4521-863c-09bb0b55e2a9 | 2026-09-09 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | b8b77421-d687-45aa-82f6-d49bce644c10 | 2026-08-31 | Warnings, Adverse reactions | LX22YL083G |
| Heparin Sodium | HEPARIN SODIUM | Hospira, Inc. | c8c4edd2-ee9e-4558-6b8c-b83adc242a0a | 2026-08-25 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Henry Schein, Inc. | 45dc6b8b-ed5d-40a2-8d9c-084c863ae93a | 2026-08-19 | Warnings, Adverse reactions | ZZ45AB24CA |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | df18a603-ca12-4b26-83b5-9dd07b6453ab | 2026-08-18 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.